[{"address1": "650 Castro Street", "address2": "Suite 450", "city": "Mountain View", "state": "CA", "zip": "94041", "country": "United States", "phone": "650 200 0412", "website": "https://www.altoneuroscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Dr. Amit  Etkin M.D., Ph.D.", "age": 47, "title": "Founder, Chairman of the Board, CEO & President", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 995998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas C. Smith", "age": 35, "title": "CFO & Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 680467, "exercisedValue": 0, "unexercisedValue": 217377}, {"maxAge": 1, "name": "Mr. Michael C. Hanley M.B.A.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 623006, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dan  Segal B.Sc. (Hons), BCom, CA, MSc", "age": 62, "title": "Co-Founder & Strategic Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin R. McQuade J.D.", "age": 49, "title": "General Counsel, Chief Administrative Officer & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Savitz M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579569, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Powell", "age": 49, "title": "Chief Development Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.02, "open": 6.03, "dayLow": 5.52, "dayHigh": 6.15, "regularMarketPreviousClose": 6.02, "regularMarketOpen": 6.03, "regularMarketDayLow": 5.52, "regularMarketDayHigh": 6.15, "payoutRatio": 0.0, "forwardPE": -1.9651568, "volume": 301549, "regularMarketVolume": 301549, "averageVolume": 1115742, "averageVolume10days": 6607600, "averageDailyVolume10Day": 6607600, "bid": 5.66, "ask": 5.65, "bidSize": 2, "askSize": 1, "marketCap": 152712176, "fiftyTwoWeekLow": 1.6, "fiftyTwoWeekHigh": 15.04, "allTimeHigh": 24.0, "allTimeLow": 1.6, "fiftyDayAverage": 3.9586, "twoHundredDayAverage": 3.22725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 30436188, "profitMargins": 0.0, "floatShares": 17884113, "sharesOutstanding": 27076629, "sharesShort": 1641893, "sharesShortPriorMonth": 1700751, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.060599998, "heldPercentInsiders": 0.0748, "heldPercentInstitutions": 0.64048, "shortRatio": 20.73, "shortPercentOfFloat": 0.077, "impliedSharesOutstanding": 27076629, "bookValue": 4.559, "priceToBook": 1.2371134, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -64859000, "trailingEps": -2.39, "forwardEps": -2.87, "enterpriseToEbitda": -0.437, "52WeekChange": -0.5945363, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 5.64, "targetHighPrice": 15.0, "targetLowPrice": 4.0, "targetMeanPrice": 11.0, "targetMedianPrice": 10.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 147584992, "totalCashPerShare": 5.451, "ebitda": -69609000, "totalDebt": 25309000, "quickRatio": 18.155, "currentRatio": 18.434, "debtToEquity": 20.508, "returnOnAssets": -0.24716, "returnOnEquity": -0.42785, "freeCashflow": -38465000, "operatingCashflow": -55082000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANRO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1706884200000, "postMarketChangePercent": -2.414893, "postMarketPrice": 5.5038, "postMarketChange": -0.13619995, "regularMarketChange": -0.38, "regularMarketDayRange": "5.52 - 6.15", "fullExchangeName": "NYSE", "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.39, "epsForward": -2.87, "shortName": "Alto Neuroscience, Inc.", "corporateActions": [], "postMarketTime": 1760140800, "regularMarketTime": 1760126402, "exchange": "NYQ", "messageBoardId": "finmb_1675972978", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 1.6813998, "fiftyDayAverageChangePercent": 0.42474607, "twoHundredDayAverageChange": 2.4127498, "twoHundredDayAverageChangePercent": 0.74761784, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -6.31229, "regularMarketPrice": 5.64, "marketState": "CLOSED", "averageDailyVolume3Month": 1115742, "fiftyTwoWeekLowChange": 4.04, "fiftyTwoWeekLowChangePercent": 2.5249999, "fiftyTwoWeekRange": "1.6 - 15.04", "fiftyTwoWeekHighChange": -9.4, "fiftyTwoWeekHighChangePercent": -0.625, "fiftyTwoWeekChangePercent": -59.45363, "earningsTimestampStart": 1763150400, "earningsTimestampEnd": 1763150400, "displayName": "Alto Neuroscience", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]